SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Septerna, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$36.38+0.03 (+0.08%)

Close on Oct 19, 2026

Market cap: $1.64B
P/E (TTM): –
Dividend yield: –

Dividends

Septerna has not reported a dividend

No dividend per share appears in Septerna's annual filings since fiscal 2022.

Where these numbers come from

Parsed from the XBRL in Septerna's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SEPN.

Operating margin-44.0% · median -57.6%

Net margin-24.5% · median -54.9%

Company	Revenue	Growth
SEPN	$98.88M	+13520.1%
ENTA	$65.26M	–
VTVT	$36.84M	+216600.0%
AMLX	–	–
FULC	–	–
WVE	–	–

Company

Next earnings (est.): Nov 9, 2026, before open
Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 130
Held by institutions: 100.0%
Auditor: Ernst & Young LLP
SEC CIK: 1984086

Advertisement
300 × 250